Valuation: Guizhou Bailing Group Pharmaceutical Co., Ltd.

Market Cap 5.58B 837M 760M 702M 633M 1.2B 78.22B 1.24B 8.46B 3.35B 42.21B 3.14B 3.07B 133B P/E 2024
193x
P/E 2025 -54.4x
Enterprise Value 6.46B 968M 879M 812M 733M 1.38B 90.48B 1.44B 9.79B 3.87B 48.82B 3.63B 3.56B 154B EV / Sales 2024
1.74x
EV / Sales 2025 2.23x
Free-Float
66.81%
Yield 2024 *
-
Yield 2025 -
1 day-0.73%
1 week-7.26%
Current month-8.09%
1 month-9.51%
3 months-10.89%
6 months-16.19%
Current year-5.98%
1 week 4.03
Extreme 4.03000000
4.42
1 month 4.03
Extreme 4.03000000
4.64
Current year 4.03
Extreme 4.03000000
5.47
1 year 4.03
Extreme 4.03000000
5.92
3 years 2.98
Extreme 2.98
8.8
5 years 2.98
Extreme 2.98
11.97
10 years 2.98
Extreme 2.98
22.19
Manager TitleAgeSince
Chief Executive Officer 56 2015-04-01
Director of Finance/CFO 41 2020-12-28
Corporate Officer/Principal 42 2014-01-26
Director TitleAgeSince
Chairman 56 2026-03-26
Director/Board Member 58 2007-12-24
Director/Board Member 42 2014-01-26
Date Insider Type Main position Quantity % Market Cap. Importance
9/21/20 Sell

Chairman

1,940,600 0.2495%
9/18/20 Sell

Director

3,670,000 0.4719%
9/18/20 Sell

Chairman

296,500 0.0381%
Change 5-day change 1-year change 3-year change Capi.($)
-0.73%-7.26%-31.95%-50.72% 837M
-1.13%-1.17%+38.55%+139.23% 1,261B
-1.36%-0.74%+39.64%+86.06% 671B
-0.59%-0.36%+25.14%+111.73% 518B
-0.76%+1.10%+41.43%+70.96% 387B
-0.75%-3.16%+54.39%+40.90% 353B
-1.83%-0.89%+26.00%+58.48% 300B
-1.65%-0.59%+1.55%+34.52% 283B
-0.95%-1.57%+34.01%+72.55% 248B
+1.60%-0.36%+37.21%+125.66% 211B
Average -0.81%-1.08%+26.60%+68.94% 423B
Weighted average by Cap. -0.97%-0.55%+34.96%+95.65%

Financials

2024 2025
Net sales 3.83B 574M 521M 481M 434M 819M 53.6B 851M 5.8B 2.29B 28.92B 2.15B 2.11B 91.38B 3.05B 457M 415M 383M 346M 653M 42.71B 678M 4.62B 1.83B 23.05B 1.72B 1.68B 72.82B
Net income 33.62M 5.04M 4.58M 4.23M 3.81M 7.2M 471M 7.48M 50.95M 20.15M 254M 18.92M 18.52M 803M -104M -15.65M -14.21M -13.12M -11.84M -22.35M -1.46B -23.21M -158M -62.55M -789M -58.72M -57.48M -2.49B
Net Debt 1.4B 210M 191M 176M 159M 300M 19.62B 311M 2.12B 839M 10.59B 788M 771M 33.45B 875M 131M 119M 110M 99.23M 187M 12.25B 195M 1.33B 524M 6.61B 492M 482M 20.89B
Projected Income Statement - Annual - Guizhou Bailing Group Pharmaceutical Co., Ltd.
Logo Guizhou Bailing Group Pharmaceutical Co., Ltd.
Guizhou Bailing Group Pharmaceutical Co Ltd is a China-based company principally engaged in the research and development, production and sales of Miao medicine. The Company operates four segments. The Industrial segment is mainly engaged in the research and development, production and sales of Chinese patent medicine tablets, capsules and syrups. The Commercial segment is mainly engaged in drug distribution and big health business. The Medical Institution segment mainly operates diabetes hospitals. Other segment mainly provides Chinese medicinal materials and are engaged in organic fertilizer manufacturing, water production and supply and other businesses. The Company's products include Yindan Xinnaotong soft capsules, Kesuting syrup and capsules, Shuangyang Houbitong granules and non-Miao medicine products Jingan capsules, Vitamin C Yinqiao tablets, Xiaoer Chaigui antipyretic granules and other products. The Company mainly conducts its businesses in the domestic market.
Employees
5,715
Date Price Change Volume
26-11-17 CN¥4.090 -0.73% 9,351,606
26-11-16 CN¥4.120 -2.83% 8,521,654
26-11-13 CN¥4.240 -2.97% 8,594,600
26-11-12 CN¥4.370 -1.13% 6,607,200
26-11-11 CN¥4.420 +0.23% 3,850,100

Annual profits - Rate of surprise

Rate of surprise - EPS - Annual - Guizhou Bailing Group Pharmaceutical Co., Ltd.
  1. Stock Market
  2. Stocks
  3. 002424 Stock